EpiScreen: Early Epilepsy Detection from Electronic Health Records with Large Language Models

arXiv cs.CL / 3/31/2026

📰 NewsSignals & Early TrendsIdeas & Deep AnalysisModels & Research

Key Points

  • The paper introduces EpiScreen, a low-cost method for early epilepsy detection that leverages routinely collected clinical notes from electronic health records rather than relying on costly video-EEG.
  • By fine-tuning large language models on labeled notes, EpiScreen reports strong performance, reaching up to 0.875 AUC on MIMIC-IV and 0.980 AUC on a private University of Minnesota cohort.
  • In clinician–AI collaboration tests, neurologists assisted by EpiScreen reportedly outperformed unaided experts by up to 10.9%, suggesting practical decision support benefits.
  • The study frames EpiScreen as a way to reduce misdiagnosis-driven diagnostic delays and unnecessary interventions, especially in resource-limited settings.
  • Overall, the work demonstrates how LLMs can be adapted for clinical screening workflows using existing EHR text data to improve timeliness and accessibility of seizure diagnosis.

Abstract

Epilepsy and psychogenic non-epileptic seizures often present with similar seizure-like manifestations but require fundamentally different management strategies. Misdiagnosis is common and can lead to prolonged diagnostic delays, unnecessary treatments, and substantial patient morbidity. Although prolonged video-electroencephalography is the diagnostic gold standard, its high cost and limited accessibility hinder timely diagnosis. Here, we developed a low-cost, effective approach, EpiScreen, for early epilepsy detection by utilizing routinely collected clinical notes from electronic health records. Through fine-tuning large language models on labeled notes, EpiScreen achieved an AUC of up to 0.875 on the MIMIC-IV dataset and 0.980 on a private cohort of the University of Minnesota. In a clinician-AI collaboration setting, EpiScreen-assisted neurologists outperformed unaided experts by up to 10.9%. Overall, this study demonstrates that EpiScreen supports early epilepsy detection, facilitating timely and cost-effective screening that may reduce diagnostic delays and avoid unnecessary interventions, particularly in resource-limited regions.